114 related articles for article (PubMed ID: 8773936)
1. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique.
Hughes PM; Krishnamoorthy R; Mitra AK
J Ocul Pharmacol Ther; 1996; 12(2):209-24. PubMed ID: 8773936
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
3. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis.
Macha S; Duvvuri S; Mitra AK
Curr Eye Res; 2004 Feb; 28(2):77-84. PubMed ID: 14972713
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir delivery through an intravitreal microdialysis probe in rabbit.
Waga J
Acta Ophthalmol Scand; 2000 Jun; 78(3):369-71. PubMed ID: 10893076
[TBL] [Abstract][Full Text] [Related]
5. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis.
Macha S; Mitra AK
Drug Metab Dispos; 2002 Jun; 30(6):670-5. PubMed ID: 12019194
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
7. Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals.
Janoria KG; Boddu SH; Natesan S; Mitra AK
J Ocul Pharmacol Ther; 2010 Jun; 26(3):265-71. PubMed ID: 20565313
[TBL] [Abstract][Full Text] [Related]
8. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir.
Majumdar S; Kansara V; Mitra AK
J Ocul Pharmacol Ther; 2006 Aug; 22(4):231-41. PubMed ID: 16910863
[TBL] [Abstract][Full Text] [Related]
9. Preparation and ocular pharmacokinetics of ganciclovir liposomes.
Shen Y; Tu J
AAPS J; 2007 Dec; 9(3):E371-7. PubMed ID: 18170984
[TBL] [Abstract][Full Text] [Related]
10. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
Zhang JJ; Gao CF; Wang LY
Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
[TBL] [Abstract][Full Text] [Related]
11. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis.
Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment.
Wang Q; Sun C; Xu B; Tu J; Shen Y
Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826
[TBL] [Abstract][Full Text] [Related]
13. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis.
Kunou N; Ogura Y; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Ikada Y
J Control Release; 2000 Aug; 68(2):263-71. PubMed ID: 10925134
[TBL] [Abstract][Full Text] [Related]
14. Posterior segment ocular pharmacokinetics using microdialysis in a conscious rabbit model.
Dias CS; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):300-5. PubMed ID: 12506088
[TBL] [Abstract][Full Text] [Related]
15. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.
Dias C; Nashed Y; Atluri H; Mitra A
Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558
[TBL] [Abstract][Full Text] [Related]
16. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina.
Janoria KG; Boddu SH; Wang Z; Paturi DK; Samanta S; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2009 Feb; 25(1):39-49. PubMed ID: 19232011
[TBL] [Abstract][Full Text] [Related]
17. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
Macha S; Mitra AK
Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
20. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina.
Kansara V; Hao Y; Mitra AK
J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]